cGxP.wire https://validator.w3.org/feed/docs/rss2.html Blue Genes Lab Wins Endorsement for Genetic Drug Screening TISSIUM Receives CE Mark for ECLIPSIUM Hernia Repair System GeneDx Adds Long-Read Genome Sequencing for Rare Diseases Alcon Acquires Neurotech and FDA-Approved ENCELTO Summit and ECOG-ACRIN Launch Ivonescimab Trial in Biliary Cancer Teva and Sanofi Report Long-Term Duvakitug Data in IBD Zoetis Wins FDA Approval for Convenia RTU for Dogs Ionis Partner GSK Wins FDA Approval for Hibsago in Hepatitis B Okomera Signs First Commercial Platform Deal With Servier IBA Treats First Patient in ConformalFLASH Proton Therapy Trial Bioxodes Reports Positive Phase 2a BIOX-101 Stroke Data Alvotech Wins FDA Approval to Double SIMLANDI Batch Output Orikine Presents ORK1 Preclinical IBD Data at UEG Week 2026 Leads Biolabs Advances Opamtistomig to Phase II Expansion in Gastric Cancer Quoin Pharmaceuticals Publishes QRX003 Netherton Syndrome Case Report PolarityBio Wins SAWC Fall 2026 Award for Phase 3 SkinTE Study GSK Highlights Oncology Pipeline Ahead of ESMO 2026 Abbott Plans to Separate Its Global Nutrition Business Rapport Therapeutics Reports Positive RAP-219 Phase 2 Results Lumen Bio Reports Positive Phase 2 Results for LMN-201 Medicovestor Wins FDA Fast Track Designation for MC001 ADC Medtronic Wins CE Mark for New Conduction System Pacemakers Myriad Genetics Sells Prenatal Testing Business to Labcorp Abbott’s Cologuard Plus Gains CE Mark in Europe Neuromod Devices’ Lenire Added to U.S. Tinnitus Guidelines GSK Reports 61% Response Rate for Ris-Rez in Lung Cancer Disc Medicine Reports Positive Phase 3 Bitopertin Results in EPP Neurocrine Maps Lifelong Impact of Classic CAH AHN Launches RANDY’S Trial for Peritoneal Cancer Care Viatris Wins FDA Approval for Ryzumvi in Presbyopia AMCP Highlights Gaps in ESR1 Breast Cancer Biomarker Testing Revolution Medicines Starts Phase 3 Trial of Zoldonrasib in NSCLC Cannabix Delivers Breath-Based Multi-Drug Testing Panel Omada Health Study Shows Improved Weight Loss With GLP-1 Care ITM Reports Radiopharmaceutical Data at EANM 2026 HUTCHMED Closes $1.185B GSK License Deal for HMPL-A830 AstraZeneca to Present Phase III Cancer Survival Data at ESMO 2026 Veradermics Reports Positive Phase 3 Results for Oral Hair Loss Drug Summit Therapeutics Opens Phase II Trial of Ivonescimab in Kidney Cancer United Therapeutics Advances Treprostinil SMI Trial for PH-COPD TriGemX Bio Announces SPAC Merger to Advance Migraine Drug Genentech to Present Key Oncology Data at ESMO 2026 Takeda Reports VERDICT Trial Results for ENTYVIO in Ulcerative Colitis Zealand Pharma Reports Positive Phase 1 Results for ZP9830 Oculis Completes PREDICT-1 Randomization for Dry Eye Drug Evaxion Reports Three-Year EVX-01 Melanoma Vaccine Results ImmunityBio Reports Long-Term ANKTIVA Data in Bladder Cancer Alcon Wins FDA Approval for BRYTLY Redness-Relief Eye Drops Opus Genetics Wins FDA Approval for RYZUMVI in Presbyopia Organon Reports Positive Six-Year MIUDELLA Phase 3 Results